Physicians' Academy for Cardiovascular Education

Cardiovascular effects of glucose lowering: Safety vs Efficacy

3' education - Dec. 12, 2014 - AHA, Chicago VBWG - Dr Silvio E Inzucchi


Dr. Silvio E. Inzucchi, Yale School of Medicine, New haven, CT, USA, provides his perspective om current diabetes therapies and ongoing trials with DPP4 and SGLT2 inhibitors on cardiovascular safety and/or benefits

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: